Acral ischemia
Showing 1 - 25 of 2,064
Acral Melanoma Trial (camrelizumab+apatinib+TMZ, camrelizumab+apatinib, camrelizumab)
Not yet recruiting
- Acral Melanoma
- camrelizumab+apatinib+TMZ
- +2 more
- (no location specified)
Mar 16, 2023
Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi
Completed
- Cutaneous Manifestations
- +7 more
-
Karachi, Sindh, PakistanJinnah Postgraduate Medical Centre
Nov 12, 2021
Actinic Keratoses, Photodamaged Skin Trial in Truro (Ameluz)
Suspended
- Actinic Keratoses
- Photodamaged Skin
-
Truro, Cornwall, United KingdomRoyal Cornwall Hospital
Jul 29, 2022
Therapies in Acromegaly Disease: Acral Morpho-functional Study
Recruiting
- Acromegaly
- Medical surgery therapy
-
Milano, ItalyIstituto Auxologico Italiano IRCCS San Luca
Jul 25, 2023
Acral Lentiginous Melanoma Trial in Hong Kong (pembrolizumab)
Active, not recruiting
- Acral Lentiginous Melanoma
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Feb 15, 2022
Ulcer, Acral Nevus, Scleroderma Trial in Firenze (EmoLED treatment, current Standard of Care)
Recruiting
- Ulcer
- +3 more
- EmoLED treatment
- current Standard of Care
-
Firenze, ItalyAOU Careggi - SOD Reumatologia - Scleroderma Unit
Apr 29, 2022
Locally Advanced or Metastatic Acral Malignant Melanoma Trial in Jinan (Toripalimab and Anlotinib)
Not yet recruiting
- Locally Advanced or Metastatic Acral Malignant Melanoma
- Toripalimab and Anlotinib
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Oct 8, 2021
Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)
Terminated
- Unresectable, Recurrent or Metastatic Melanoma
- Untreated Mucosal or Acral Lentiginous Melanoma
-
Beijing, Beijing, China
- +12 more
Apr 12, 2022
Chronic Limb-Threatening Ischemia Trial in Košice (lumbar sympathetic blockade)
Recruiting
- Chronic Limb-Threatening Ischemia
- lumbar sympathetic blockade
-
Košice, SlovakiaEuropainclinics
Oct 26, 2023
Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1
Recruiting
- Carcinoma, Renal Cell
- Kidney Neoplasms
-
Yiwu, Zhejiang, ChinaThe Fourth Affiliated Hospital Zhejiang University School of Med
Mar 27, 2023
Liver Ischemia-reperfusion Injury and Clinical Data Analysis
Recruiting
- Liver Injury
- No intervention
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 6, 2023
Breast Tumors Trial in Guangzhou (Cold dissection, Electrocautery Dissection)
Recruiting
- Breast Neoplasms
- Cold dissection
- Electrocautery Dissection
-
Guangzhou, Guangdong, ChinaShicheng Su
Sep 4, 2023
Early Warning of Delayed Cerebral Ischemia
Recruiting
- Subarachnoid Hemorrhage, Aneurysmal
- +3 more
- Computed Tomography (CT) and Computed Tomography Angiography (CTA)
- Multimodal physiological monitoring
-
Vilnius, LithuaniaVilnius University Hospital Santaros klinikos
Aug 17, 2023
Restenosis After Lower Extremity Endovascular Revascularization
Recruiting
- Peripheral Artery Disease
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 25, 2023
miRNAs in Critical Limb Ischemia (miRNACLI)
Recruiting
- Critical Limb Ischemia
- Critical limb ischemia: analysis of RNAs
- Controls: analysis of RNAs
-
San Donato Milanese, Milan, ItalyIrccs Policlinico San Donato
Sep 27, 2023
Extracorporeal Membrane Oxygenation Complication Trial in Seoul (Distal perfusion catheterization)
Recruiting
- Extracorporeal Membrane Oxygenation Complication
- Distal perfusion catheterization
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 1, 2023
Hand Acceleration Time Assessment With Ultrasound Doppler
Recruiting
- Upper Limb Ischemia
- Vascular Disease
- Hand Doppler Ultrasound
-
L'Hospitalet De Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Aug 6, 2023
Coronary Disease, Percutaneous Coronary Intervention, Exercise Test Trial in New Haven (No study intervention)
Enrolling by invitation
- Coronary Disease
- +4 more
- No study intervention
-
New Haven, ConnecticutYale University School of Medicine - Section of Cardiology
Nov 9, 2022
Diabetic Retinopathy Trial in Coimbra
Recruiting
- Diabetic Retinopathy
-
Coimbra, PortugalAIBILI-CEC (AIBILI- Clinical Trials Centre)
Dec 21, 2022
Kidney Tumors Trial in Miami Lakes (Cryoablation Assisted Partial Nephrectomy)
Recruiting
- Kidney Neoplasms
- Cryoablation Assisted Partial Nephrectomy
-
Miami Lakes, FloridaUrological Research Network
Jan 24, 2023
Erythrodysesthesia Syndrome Trial (Photobiomodulation, Moisturizer)
Not yet recruiting
- Erythrodysesthesia Syndrome
- Photobiomodulation
- Moisturizer
- (no location specified)
Dec 24, 2022
Myocardial Reperfusion Injury, Treatment Outcome, Prognosis Trial (Extracorporeal cardiac shock wave therapy(ECSW))
Not yet recruiting
- Myocardial Reperfusion Injury
- +3 more
- Extracorporeal cardiac shock wave therapy(ECSW)
- (no location specified)
Nov 12, 2022
Acral Melanoma Trial in Changchun (SHR-1210+Apatinib)
Recruiting
- Acral Melanoma
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
May 24, 2021
Chronic Mesenteric Ischemia Trial in Rotterdam (Sodium butyrate, 1-13C, 99%, Cambridge Isotope Laboratories, Inc.USA, U-13C6,
Completed
- Chronic Mesenteric Ischemia
- Sodium butyrate, 1-13C, 99%, Cambridge Isotope Laboratories, Inc.USA
- +3 more
-
Rotterdam, NetherlandsErasmus Medical Center - Department of Gastroenterology
Aug 30, 2023